537 results about "Total cholesterol" patented technology

The present invention is directed to methods of reducing plasma triglyceride level in subjects by administering docosahexaenoic acid (DHA). The method can comprise administering daily to the subject a dosage form comprising docosahexaenoic acid ester substantially free of eicosapentaenoic acid (EPA), wherein the DHA is derived from an algal source. In some embodiments, the method comprises administering daily to the subject a dosage form comprising DHA ester substantially free of EPA, wherein the DHA ester is about 60% to about 99.5% (w/w) of the total fatty acid content of the dosage form. In some embodiments, the method comprises administering daily to the subject a dosage form comprising about 200 mg to about 4 g of DHA ester substantially free of EPA. In some embodiments, the foregoing methods also result in a lowering of the amount of total cholesterol in the subject.

A composition is provided containing at least 90% of policosanols obtained from rice bran wax, wherein the policosanols contain from about 25 to about 35% of octacosanol, and its use in providing significant improvements in total cholesterol and/or LDL reduction in subjects in need thereof.

The invention relates to the technical field of microorganism, and discloses a Lactobacillus reuteri and its application. The preservation number of the Lactobacillus reuteri CCFM8631 is CGMCC No.14394; the level of mice peripheral neurotransmitter 5-hydroxytryptamine can be significantlyimproved; the rise of the mice peripheral blood testonsterone level and the abundant abnormity of Blautia, Turicibacter, Oscillospira and Bifidobacterium in the intestinal flora by high glucose and high fatty diets are recovered; the tolerated simulative gastrointestinal fluid is rapidly planted in an intestinal tract, so as to significantly improve the pathological injury of metabolic syndrome mice liver and duodenum and rise of triglyceride and total cholesterol content in the serum by high glucose and high fatty diets are significantly improved; the Lactobacillus reuteri can be used for preventing, delaying or treating metabolic disorder such as metabolic syndrome, irritable bowel syndrome, and anxiety, depression and other metal diseases related to irritable bowel syndrome.

A composition is provided which contains policosanol and HMG-Co-A reductase inhibitor and which may be used for treating and or reducing hypercholesterolemic diseases, total cholesterol, LDL-cholesterol, coronary heart disease (heart attacks and strokes), inflammation, deep-vein thrombosis immunoregulatory diseases, cardiovascular diseases, and/or neurodegenerative disorders in humans and animals. The method comprises administering policosanol and HMG-Co-A reductase inhibitor which together effectively lower serum cholesterol levels. Typically, the administered composition includes about 0.1-10:1 parts by weight of policosanol to HMG-Co-A reductase inhibitor.

A method and system for treating non-alcoholic fatty liver disease (NAFLD) involves the modulation of the gut microbial of a person suffering from NAFLD, and in particular the provision of a probiotic therapy configured to reduce liver aminotransferases, total-cholesterol, TNF-α and to improve insulin resistance in NAFLD patients.

Methods of treating high serum levels of total cholesterol, low density lipoprotein and triglycerides in a mammal by administering therapeutically effective doses of N-(4-{[4-(3,4-dichlorophenyl)-1,3-thiazol-2-yl]amino}phenyl)acetamide or a salt thereof such as a hydrochloride or hydrobromide salt.

The invention provides Chinese herbal medicine additive for improving meat quality of java tilapia, containing by weight of: 22-30% of spatholobus stem, 30-40% of black bean, 10-15% of glycyrrhiza, 5-10% of honeysuckle, 5-10% of radix isatidis and 10-15% of hawthorn. The advantages of the invention comprise: (1) having good phagostimulant effect, (2) substantially reducing fat content and cholesterol level in muscles of java tilapia, substantially increasing flavor substance content of inosinic acid in muscles, improving muscles quality of java tilapia, (3), adding and using conveniently, and directly adding in commercial feedstuff, wherein the components can generates synergistic effect with other additive components in commercial feedstuff, and raise weighting rate and disease resistance of java tilapia, and (4) having stabile raw material resource, low price, simple production process and easy for industrialization production.

The invention relates to a probiotic composition, and discloses a probiotic composition beneficial for a glycolipid metabolic function and a preparation and application of the composition. The probiotic composition comprises some of the following nine probiotics: bifidobacterium longum, bifidobacterium breve, lactobacillus gasseri, lactobacillus rhamnosus, lactobacillus salivarius, lactobacillus crispatus, lactobacillus plantarum, lactobacillus fermentum and lactobacillus casei. Different strains in the probiotic composition cooperate with each other, so that the probiotic composition has thefunction of adjusting glycolipid metabolism, and has certain effect on serum total cholesterol, triglycerides, insulin beta-cell functions and diabetes mellitus improvement.

The invention features bioactive compounds obtainable from goldenseal and methods of use of such compounds in reducing lipid (at least one of total cholesterol, LDL-cholesterol, free fatty acids, or triglycerides) in a patient having or suspected of having hyperlipidemia.

There is provided a therapy for lowering the blood levels of a lipid selected from the group comprising LDL cholesterol, triglycerides, overall cholesterol and mixtures thereof, the therapy comprising the step of administering an effective amount of one or more phosphate derivatives of one or more electron transfer agents.

The invention relates to a preparation method of an adsorbent for adsorbing low-density lipoprotein (LDL) for whole blood perfusion. The preparation method comprises the following steps: performing chloromethylation modification and hydroxylation modification on polystyrene adsorption resin, then performing epichlorohydrin activation to ensure that the surface of the polystyrene macroporous adsorption resin carries a great quantity of active groups, and further immobilizing polyanion ligands onto the polystyrene macroporous adsorption resin. The whole blood perfusion adsorbent with excellent adsorption performance on LDL, TG (triglyceride) and TC (total cholesterol) is prepared by combining the electronegativity of polyanion, the hydrophobicity of a polystyrene resin skeleton structure and the pore adsorption action of the macroporous adsorption resin.

The invention discloses a large data cardiovascular disease risk monitoring system. According to the system, personal information (including age, sex, blood pressure, height, weight, obesity index and the like) of health examinations, physical examinations and hospital treatment, and test data of blood routine, blood biochemistry and myocardial enzymes are used for monitoring the cardiovascular disease risk. The invention belongs to the application of large data in the field of health care, and further belongs to the crossing technical field of large data and health care. The invention aims at providing a simple, easy, practical and accurate cardiovascular risk monitoring system. The current monitoring of the cardiovascular disease risk is achieved mostly by enquiring a small sample amount of data collected by a questionnaire method such as disease history, family history and major risk factors for the cardiovascular disease and through the data of blood sugar collected by an instrument, total cholesterol and the like. The monitoring is controlled and managed by medical institutions and doctors so that users can not carry out the monitoring of the cardiovascular disease risk by themselves. Due to the fact that epidemiological features of a cardiovascular disease spectrum and risk factors in Chinese population are significantly different from the epidemiological features in western developed countries. The existing risk assessment tools in Europe and America are not suitable for the Chinese population. With the help of a large data value extraction technology, the large data cardiovascular disease risk monitoring system can monitor the cardiovascular disease risk for users and doctors and provide hope for human to monitor the cardiovascular disease risk by themselves and conquer the cardiovascular disease.

The present invention relates to a fermented coconut milk drink and a preparation method thereof, the fermented coconut milk drink is prepared from coconut milk, syrup or a sugar substitute, and pure water as raw materials for fermentation by selected plant lactobacillus, the fermented coconut milk drink is prepared by the method is unique in flavor, nutrient-rich, and smooth and fresh in taste, the short chain fatty acid level of the fermented coconut milk drink is significantly improved after fermentation by the plant lactobacillus, and the fermented coconut milk drink can significantly reduce total cholesterol (TC) and triglyceride (TG) content in fasting blood-glucose and blood fat of hyperlipemia rats, and has significant health benefits.

The present invention relates to a sampling device for taking up a blood sample and for providing the blood sample for analysis of total cholesterol in said blood sample. The device comprises a receiving cavity for receiving, through capillary action, the blood sample to be analysed, said receiving cavity having a predetermined small volume; and an analysis cavity, arranged in communication with the receiving cavity, said analysis cavity having a predetermined optical path length. The receiving cavity contains a dried buffer, and the analysis cavity contains a dried reagent. The invention also relates to a method for quantitative determination of the total cholesterol concentration in a blood sample of serum/plasma by end point analysis.

The invention relates to a health-care food composite with a function of assisting in reducing blood fat and a preparation method thereof. According to the invention, 100-200 parts by weight of freeze-dried natto powder, 100-200 parts by weight of red yeast, 100-220 parts by weight of phytosterol and clinically acceptable auxiliary materials are prepared into hard capsules, tablets, granules and powder. According to the invention, a complementary concept is adopted, and through the combination of three kinds of raw materials, the serum total cholesterol can be effectively reduced, and the triglyceride can be reduced, therefore, the health-care food composite has a health-care function of assisting in reducing blood fat; and in each 100g of the health-care food composite, the weight of the efficacy component phytosterol is higher than 10 g, and the weight of lovastatin is higher than 0.1 g.

The invention provides a planting method of underwood grassland for breeding chickens, which pertains to the agricultural technical field. The method comprises the following steps: firstly, a forest land with a canopy density less than 70 percent is selected; secondly, purple alfalfa and chicory are sowed in a mixed way according to a percentage by seed weight of 30 to 60 percent and 70 to 40 percent, namely, each kilogram of mixed sowing seeds contains 0.3 to 0.6kg of purple alfalfa seeds and 0.7 to 0.4kg of chicory seeds, the sowing rate is 1.5 to 3.0 kg/mu (mu: a Chinese unit of area, 1/15 of a hectare), thereby forming an underwood grassland for breeding chickens, which can improve the immunizing ability of the chickens but reduce the total cholesterol content in the chickens. Breeding and utilizing the grassland start when the purple alfalfa and the chicory planted on the grassland grow to an average height of 15cm. The underwood grassland of the invention is characterized by improving the immunizing ability of the chickens, reducing the total cholesterol content of the chickens, saving feed, promoting the economic benefit of ecological forests and economic forests and producing high quality chickens.

The invention belongs to the field of traditional Chinese medicines and relates to a use of rhizoma smilacis glabrae extract in preparation of lipid-lowering and fat-reducing medicines and health-care foods. The rhizoma smilacis glabrae extract comprises 5-O-caffeoylshikimic acid, astilbin, isoastilbin, neoastilbin, neoisoastilbin, taxifolin, engeletin, isoengelitin and resveratrol. An animal experiment shows that the rhizoma smilacis glabrae extract can obviously reduce mice abdominal cavity fat weight, reduce mice body weight, and reduce triglyceride and total cholesterol concentrations of mice serum. Effects of the rhizoma smilacis glabrae extract are stronger than effects of a single astilbin component. The rhizoma smilacis glabrae extract is extracted from traditional Chinese medicines, has synergism of components, has good fat-reducing effects and broadens a rhizoma smilacis glabrae application range.

The invention discloses bifidobacterium animalis NX-6 and application thereof in preparation of lipid-lowering and weight-losing medicines, and belongs to the technical field of microorganisms. The preservation number of the bifidobacterium animalis NX-6 disclosed by the invention is CGMCC (China General Microbiological Culture Collection Center) No. 20114. The uninactivated and inactivated fermentation supernate, bacterial suspension and cell disrupted supernate of novel bifidobacterium animalis NX-6 show good effects of slowing down weight and body length increase, improving body mass index(BMI) and reducing fat area percentage on zebrafish, and have a potential weight losing effect; triglyceride (TG) and total cholesterol (TC) in a zebrafish hyperlipidemia model body can be obviously reduced, and a good hypolipidemic effect is shown. The novel bifidobacterium animalis NX-6 disclosed by the invention has a huge potential application prospect in the aspect of preparing medicines fortreating and/or preventing obesity and hyperlipidemia.

The invention relates to health-care rice vinegar and a preparation process thereof. The invention belongs to the technical field of processing of condiments and particularly relates to health-care rice vinegar prepared from millet serving as a main raw material and traditional Chinese medicinal materials. The health-care rice vinegar is prepared from the main raw material comprising millet, traditional Chinese medicinal materials comprising hawthorn, dark plum fruit, semen cassia, lotus leaf, oriental wormwood, oolong, lucid ganoderma, immature bitter orange, aloe, peach kernel, ginger and yam, and auxiliary materials comprising wheat koji, bran, cavings and salt. The health-care rice vinegar has the advantages of 1, comprehensively adjusting lipid metabolism, obviously reducing hyperlipaemia, reducing serum total cholesterol, triglyceride and low-density lipoprotein, obviously increasing high-density lipoprotein and degrading atherosclerotic plaques; 2, reducing blood viscosity, obviously inhibiting platelet abnormal coagulation, improving hemodynamic indexes, promoting blood circulation, avoiding thrombus and effectively preventing apoplexia; and 3, dredging blood vessels, improving blood supply microcirculation, improving brain and heart blood supply insufficiency, inhibiting atherosclerosis and effectively preventing coronary heart disease.